专利检索 ap:("Argenx BVBA" OR "University of Bern") AND inv:"RIETHER, Carsten" 第 1 页

1.

发明公开
USE OF ANTI CD70 ANTIBODY ARGX-110 TO TREAT ACUTE MYELOID LEUKAEMIA 审中-公开

公开(公告)号：EP3638696A1

公开(公告)日：2020-04-22

申请号：EP18732064.3

申请日：2018-06-18

申请人： Argenx BVBA , University of Bern

发明人： LEUPIN, Nicolas , VAN ROMPAEY, Luc , DE HAARD, Hans , OCHSENBEIN, Adrian , RIETHER, Carsten

IPC分类号： C07K16/28 , A61K39/00

2.

发明公开
CD70 AND VENETOCLAX, A BCL-2 INHIBITOR, COMBINATION THERAPY FOR TREATING ACUTE MYELOID LEUKEMIA 审中-公开

公开(公告)号：EP3890740A1

公开(公告)日：2021-10-13

申请号：EP19831677.0

申请日：2019-12-18

申请人： Argenx BVBA , University of Bern

发明人： DE HAARD, Hans , FUNG, Samson , LEUPIN, Nicolas , VAN ROMPAEY, Luc , OCHSENBEIN, Adrian , RIETHER, Carsten

IPC分类号： A61K31/496 , A61K39/395 , A61P35/00 , C07D471/04 , C07K16/28

3.

发明公开
CD70 AND VENETOCLAX, A BCL-2 INHIBITOR, COMBINATION THERAPY FOR TREATING ACUTE MYELOID LEUKEMIA 审中-公开

公开(公告)号：EP4218761A1

公开(公告)日：2023-08-02

申请号：EP23151526.3

申请日：2019-12-18

申请人： Argenx BVBA , University of Bern

发明人： DE HAARD, Hans , FUNG, Samson , LEUPIN, Nicolas , VAN ROMPAEY, Luc , OCHSENBEIN, Adrian , RIETHER, Carsten

IPC分类号： A61K31/496 , A61K39/395 , A61P35/00 , C07D471/04 , C07K16/28

摘要： The invention relates to combination therapies, particularly combination therapies for the treatment of myeloid malignancy. The combination therapies are particularly useful in methods for the treatment of acute myeloid leukemia (AML). The combination therapies include an antibody or antigen binding fragment thereof that binds to CD70 and a BCL-2 inhibitor, preferably venetoclax or a pharmaceutically acceptable salt thereof.

4.

发明公开
USE OF ANTI CD70 ANTIBODY ARGX-110 TO TREAT ACUTE MYELOID LEUKAEMIA 审中-实审

公开(公告)号：EP4389142A2

公开(公告)日：2024-06-26

申请号：EP24160069.1

申请日：2018-06-18

申请人： argenx BV , University of Bern

发明人： LEUPIN, Nicolas , VAN ROMPAEY, Luc , DE HAARD, Hans , OCHSENBEIN, Adrian , RIETHER, Carsten

IPC分类号： A61K39/00

CPC分类号： A61K2039/50520130101 , C07K2317/2220130101 , C07K2317/2420130101 , C07K2317/4120130101 , C07K2317/73220130101 , C07K2317/73420130101 , C07K2317/7620130101 , C07K2317/9420130101 , A61K45/06 , C07K16/2875 , A61P35/02 , A61K31/706 , A61K39/39558

摘要： Methods of treating acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS) are provided, as are compositions and combinations suitable for use in said methods.

5.

发明公开
USE OF ANTI CD70 ANTIBODY ARGX-110 TO TREAT ACUTE MYELOID LEUKAEMIA 审中-实审

公开(公告)号：EP4389142A3

公开(公告)日：2024-08-21

申请号：EP24160069.1

申请日：2018-06-18

申请人： argenx BV , University of Bern

发明人： LEUPIN, Nicolas , VAN ROMPAEY, Luc , DE HAARD, Hans , OCHSENBEIN, Adrian , RIETHER, Carsten

IPC分类号： C07K16/28 , A61P35/00 , A61K39/00

CPC分类号： A61K2039/50520130101 , C07K2317/2220130101 , C07K2317/2420130101 , C07K2317/4120130101 , C07K2317/73220130101 , C07K2317/73420130101 , C07K2317/7620130101 , C07K2317/9420130101 , A61K45/06 , C07K16/2875 , A61P35/02 , A61K31/706 , A61K39/39558 , A61P35/00

摘要： Methods of treating acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS) are provided, as are compositions and combinations suitable for use in said methods.